MPS Ltd Share Price – NSE /  BSE

IT - Software, Small Cap

The Board of MPS at the meeting held on 15th May 2026, has decided not to recommend a final dividend for the financial year 2025-26.

Net profit of MPS declined 0.06% to Rs 47.04 crore in the quarter ended March 2026 as against Rs 47.07 crore during the previous quarter ended March 2025. Sales rose 12.66% to Rs 205.16 crore in the quarter ended March 2026 as against Rs 182.11 crore during the previous quarter ended March 2025.

For the full year,net profit rose 16.33% to Rs 173.22 crore in the year ended March 2026 as against Rs 148.91 crore during the previous year ended March 2025. Sales rose 5.71% to Rs 768.37 crore in the year ended March 2026 as against Rs 726.89 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

MPS will hold a meeting of the Board of Directors of the Company on 15 May 2026.

MPS announced that its wholly owned subsidiary, MPS North America LLC has concluded the acquisition of 100% stake in Unbound Medicine Inc., USA for a total consideration of USD 16.5 million. Accordingly, Unbound Medicine, Inc., USA has become a wholly-owned step-down subsidiary of MPS.

Powered by Capital Market - Live News